Literature DB >> 17424936

Topoisomerase I inhibition and cytotoxicity of licochalcones A and E from Glycyrrhiza inflata.

Goo Yoon1, Bok Yun Kang, Seung Hoon Cheon.   

Abstract

Licochalcones A (1) and E (2), retrochalcones or reversely constructed chalcones, isolated from the roots of Glycyrrhiza inflata, were evaluated for their cytotoxicities against four different human tumor cell lines; A549 (lung), SK-OV-3 (ovarian), SK-MEL-2 (melanoma) and HCT-15 (colon), using the sulforhodamine B (SRB) assay. The effects of these compounds toward the DNA topoisomerase I (topo I) inhibitory activity were also measured using the supercoiled DNA unwinding assay. All compounds showed moderate cytotoxicities against the four different human tumor cell lines and inhibited the topo I activity in dose-dependent manners. The inhibition of topo I by licochalcones A (1) and E (2) may explain the cytotoxicities of these compounds against the human tumor cell lines.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17424936     DOI: 10.1007/bf02977611

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  12 in total

Review 1.  The role of chalcones in suppression of NF-κB-mediated inflammation and cancer.

Authors:  Vivek R Yadav; Sahdeo Prasad; Bokyung Sung; Bharat B Aggarwal
Journal:  Int Immunopharmacol       Date:  2010-12-22       Impact factor: 4.932

Review 2.  Anticancer activities of phytoconstituents and their liposomal targeting strategies against tumor cells and the microenvironment.

Authors:  Jing Zhang; Xiang Li; Leaf Huang
Journal:  Adv Drug Deliv Rev       Date:  2020-05-28       Impact factor: 15.470

Review 3.  Applications of Friedel-Crafts reactions in total synthesis of natural products.

Authors:  Majid M Heravi; Vahideh Zadsirjan; Pegah Saedi; Tayebeh Momeni
Journal:  RSC Adv       Date:  2018-12-03       Impact factor: 4.036

4.  Structure-activity relationships of retro-dihydrochalcones isolated from Tacca sp.

Authors:  Jiangnan Peng; April L Risinger; Chenxiao Da; Gary A Fest; Glen E Kellogg; Susan L Mooberry
Journal:  J Nat Prod       Date:  2013-12-04       Impact factor: 4.050

5.  Secondary metabolites as DNA topoisomerase inhibitors: A new era towards designing of anticancer drugs.

Authors:  Supriya Baikar; Nutan Malpathak
Journal:  Pharmacogn Rev       Date:  2010-01

6.  Crystal structure of 5-(4-methyl-phen-yl)-3-[(E)-2-(4-methyl-phen-yl)ethen-yl]cyclo-hex-2-en-1-one.

Authors:  Joel T Mague; Shaaban K Mohamed; Mehmet Akkurt; Antar A Abdelhamid; Mustafa R Albayati
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-05-07

7.  Licochalcone Suppresses LXRα-Induced Hepatic Lipogenic Gene Expression through AMPK/Sirt1 Pathway Activation.

Authors:  Jae Yun Han; Sun Hee Park; Ji Hye Yang; Mi Gwang Kim; Seung Sik Cho; Goo Yoon; Seung Hoon Cheon; Sung Hwan Ki
Journal:  Toxicol Res       Date:  2014-03

8.  Simultaneous Determination of Nine Active Compounds of the Traditional Chinese Medicinal Prescription Shaoyao-Gancao-Tang and Analysis of the Relationship between Therapeutical Effect and Compatibility of Medicines.

Authors:  Guangwei Zhu; Guijun Zhang; Meng Wang; Jingjuan Wang; Weixin Zeng; Xiaomei Gao
Journal:  Evid Based Complement Alternat Med       Date:  2014-11-06       Impact factor: 2.629

9.  Simultaneous Determination of 8 Compounds in Gancao-Ganjiang-Tang by HPLC-DAD and Analysis of the Relations between Compatibility, Dosage, and Contents of Medicines.

Authors:  Yanfang Yang; Guijun Zhang; Qiyu Sun; Liang Liu; Hui Peng; Jingjuan Wang; Li Xiang
Journal:  Evid Based Complement Alternat Med       Date:  2017-05-14       Impact factor: 2.629

10.  Licocalchone-C extracted from Glycyrrhiza glabra inhibits lipopolysaccharide-interferon-γ inflammation by improving antioxidant conditions and regulating inducible nitric oxide synthase expression.

Authors:  Sara Franceschelli; Mirko Pesce; Isabella Vinciguerra; Alessio Ferrone; Graziano Riccioni; Antonia Patruno; Alfredo Grilli; Mario Felaco; Lorenza Speranza
Journal:  Molecules       Date:  2011-07-06       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.